Published in BMC Med Ethics on June 19, 2008
The quality of informed consent: mapping the landscape. A review of empirical data from developing and developed countries. J Med Ethics (2012) 1.69
Ethics and electronic health information technology: challenges for evidence-based medicine and the physician-patient relationship. Ghana Med J (2011) 1.09
Effect of child health status on parents' allowing children to participate in pediatric research. BMC Med Ethics (2013) 1.03
Tailoring information provision and consent processes to research contexts: the value of rapid assessments. J Empir Res Hum Res Ethics (2012) 1.01
Comparison of group counseling with individual counseling in the comprehension of informed consent: a randomized controlled trial. BMC Med Ethics (2010) 0.94
A mixed-methods study on perceptions towards use of Rapid Ethical Assessment to improve informed consent processes for health research in a low-income setting. BMC Med Ethics (2014) 0.84
Impact of gender on the decision to participate in a clinical trial: a cross-sectional study. BMC Public Health (2014) 0.80
Informed consent in paediatric critical care research--a South African perspective. BMC Med Ethics (2015) 0.76
A Comparison of the Quality of Informed Consent for Clinical Trials of an Experimental Hookworm Vaccine Conducted in Developed and Developing Countries. PLoS Negl Trop Dis (2017) 0.75
National Human Research Ethics: A Preliminary Comparative Case Study of Germany, Great Britain, Romania, and Sweden. Ethics Behav (2015) 0.75
International ethical guidelines for biomedical research involving human subjects. Bull Med Ethics (2002) 12.36
Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA (2004) 7.97
Vitamin A supplementation in northern Ghana: effects on clinic attendances, hospital admissions, and child mortality. Ghana VAST Study Team. Lancet (1993) 5.20
Impact of permethrin impregnated bednets on child mortality in Kassena-Nankana district, Ghana: a randomized controlled trial. Trop Med Int Health (1996) 4.88
Comprehension during informed consent in a less-developed country. Lancet (2002) 4.46
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ (2005) 3.87
Understanding of informed consent in a low-income setting: three case studies from the Kenyan Coast. Soc Sci Med (2004) 3.20
Beyond informed consent. Bull World Health Organ (2004) 3.07
The informed consent process in a rural African setting: a case study of the Kassena-Nankana district of Northern Ghana. IRB (2006) 2.02
An evaluation of the informed consent procedure used during a trial of a Haemophilus influenzae type B conjugate vaccine undertaken in The Gambia, West Africa. Soc Sci Med (1999) 1.84
Cultural factors constraining the introduction of family planning among the Kassena-Nankana of northern Ghana. Soc Sci Med (1997) 1.70
Problems in comprehension of informed consent in rural and peri-urban Mali, West Africa. Clin Trials (2006) 1.65
Recommendations for informed consent forms for critical care clinical trials. Crit Care Med (2005) 1.60
Evaluating the quality of informed consent. Clin Trials (2005) 1.53
Beyond the checklist: assessing understanding for HIV vaccine trial participation in South Africa. J Acquir Immune Defic Syndr (2006) 1.51
Gate-keeping and women's health seeking behaviour in Navrongo, northern Ghana. Afr J Reprod Health (2003) 1.48
Clinical research with economically disadvantaged populations. J Med Ethics (2007) 1.36
Public engagement with science? Local understandings of a vaccine trial in the Gambia. J Biosoc Sci (2005) 1.31
A case study of research ethics capacity development in Africa. Acad Med (2007) 1.28
Effects of presentation method on the understanding of informed consent. Br J Ophthalmol (2006) 1.07
Assessing recall and understanding of informed consent in a contraceptive clinical trial. Stud Fam Plann (1999) 1.02
Ethics committees in western and central Africa: concrete foundations. Dev World Bioeth (2007) 0.93
Informed consent in Indian patients. J R Soc Med (1996) 0.87
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ (2005) 3.87
Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool. Glob Health Action (2012) 3.68
An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis (2005) 3.25
Ageing and adult health status in eight lower-income countries: the INDEPTH WHO-SAGE collaboration. Glob Health Action (2010) 2.94
Revising the WHO verbal autopsy instrument to facilitate routine cause-of-death monitoring. Glob Health Action (2013) 2.69
Profile of the Navrongo Health and Demographic Surveillance System. Int J Epidemiol (2012) 2.44
Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. J Infect Dis (2002) 2.40
Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet (2007) 2.36
Malaria transmission dynamics at a site in northern Ghana proposed for testing malaria vaccines. Trop Med Int Health (2004) 2.28
Socio-cultural determinants of treatment delay for childhood malaria in southern Ghana. Trop Med Int Health (2006) 1.99
Demographic Surveillance Sites and emerging challenges in international health. Bull World Health Organ (2006) 1.93
Rapid achievement of the child survival millennium development goal: evidence from the Navrongo experiment in Northern Ghana. Trop Med Int Health (2007) 1.83
Factors affecting antenatal care attendance: results from qualitative studies in Ghana, Kenya and Malawi. PLoS One (2013) 1.72
Patterns of age-specific mortality in children in endemic areas of sub-Saharan Africa. Am J Trop Med Hyg (2007) 1.70
Seasonal profiles of malaria infection, anaemia, and bednet use among age groups and communities in northern Ghana. Trop Med Int Health (2003) 1.67
Severe falciparum malaria in young children of the Kassena-Nankana district of northern Ghana. Malar J (2007) 1.67
Integrated community case management of fever in children under five using rapid diagnostic tests and respiratory rate counting: a multi-country cluster randomized trial. Am J Trop Med Hyg (2012) 1.66
Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana. PLoS Med (2007) 1.56
Health inequalities among older men and women in Africa and Asia: evidence from eight Health and Demographic Surveillance System sites in the INDEPTH WHO-SAGE Study. Glob Health Action (2010) 1.54
Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes. Hum Mol Genet (2009) 1.50
Aligning community engagement with traditional authority structures in global health research: a case study from northern Ghana. Am J Public Health (2011) 1.49
Self-reported health and functional limitations among older people in the Kassena-Nankana District, Ghana. Glob Health Action (2010) 1.49
Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. Genome Res (2009) 1.42
The changing patterns of hypertension in Ghana: a study of four rural communities in the Ga District. Ethn Dis (2006) 1.39
Clinical case definitions and malaria vaccine efficacy. J Infect Dis (2005) 1.30
A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum. Clin Infect Dis (2003) 1.28
A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. J Infect Dis (2008) 1.27
Spatio-temporal malaria transmission patterns in Navrongo demographic surveillance site, northern Ghana. Malar J (2013) 1.27
Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana. J Infect Dis (2011) 1.26
Effectiveness of combined intermittent preventive treatment for children and timely home treatment for malaria control. Malar J (2009) 1.24
Characteristics of severe anemia and its association with malaria in young children of the Kassena-Nankana District of northern Ghana. Am J Trop Med Hyg (2002) 1.24
Changing patterns of rotavirus genotypes in ghana: emergence of human rotavirus G9 as a major cause of diarrhea in children. J Clin Microbiol (2003) 1.23
Use of health professionals for delivery following the availability of free obstetric care in northern Ghana. Matern Child Health J (2007) 1.23
Maternal mortality decline in the Kassena-Nankana district of northern Ghana. Matern Child Health J (2007) 1.21
Community concepts of malaria-related illness with and without convulsions in southern Ghana. Malar J (2005) 1.21
Stillbirths and early neonatal mortality in rural Northern Ghana. Trop Med Int Health (2011) 1.20
Clonal groupings in serogroup X Neisseria meningitidis. Emerg Infect Dis (2002) 1.20
Haematological and biochemical reference values for healthy adults in the middle belt of Ghana. PLoS One (2012) 1.20
A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana. Trop Med Int Health (2005) 1.20
Assessing malaria control in the Kassena-Nankana district of northern Ghana through repeated surveys using the RBM tools. Malar J (2007) 1.19
Clustering of under-five mortality in the Navrongo HDSS in the Kassena-Nankana District of northern Ghana. Glob Health Action (2010) 1.15
Clean delivery practices in rural northern Ghana: a qualitative study of community and provider knowledge, attitudes, and beliefs. BMC Pregnancy Childbirth (2012) 1.15
Antimalarial drug use among caregivers in Ghana. Afr Health Sci (2004) 1.13
"It's up to the woman's people": how social factors influence facility-based delivery in Rural Northern Ghana. Matern Child Health J (2014) 1.11
Emergence of W135 meningococcal meningitis in Ghana. Trop Med Int Health (2005) 1.11
Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans. PLoS Genet (2013) 1.08
Does radical cure of asymptomatic Plasmodium falciparum place adults in endemic areas at increased risk of recurrent symptomatic malaria? Trop Med Int Health (2002) 1.06
Infant nutrition in the first seven days of life in rural northern Ghana. BMC Pregnancy Childbirth (2012) 1.06
Lack of gender-specific antibody recognition of products from domains of a var gene implicated in pregnancy-associated Plasmodium falciparum malaria. Infect Immun (2003) 1.04
Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults. Malar J (2011) 1.03
HLA-DRB1*04 allele is associated with severe malaria in northern Ghana. Am J Trop Med Hyg (2008) 1.02
The economic burden of meningitis to households in Kassena-Nankana district of Northern Ghana. PLoS One (2013) 1.01
Why are babies dying in the first month after birth? A 7-year study of neonatal mortality in northern Ghana. PLoS One (2013) 0.99
Prevention and management of malaria during pregnancy: findings from a comparative qualitative study in Ghana, Kenya and Malawi. Malar J (2013) 0.99
Chasing spirits: Clarifying the spirit child phenomenon and infanticide in Northern Ghana. Soc Sci Med (2010) 0.98
Local illness concepts and their relevance for the prevention and control of malaria during pregnancy in Ghana, Kenya and Malawi: findings from a comparative qualitative study. Malar J (2013) 0.96
Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana. Malar J (2011) 0.96
Two-year evaluation of Intermittent Preventive Treatment for Children (IPTc) combined with timely home treatment for malaria control in Ghana. Malar J (2011) 0.95
Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana. Am J Trop Med Hyg (2012) 0.94
Insecticide resistance profiles for malaria vectors in the Kassena-Nankana district of Ghana. Malar J (2009) 0.92
Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria. J Trop Pediatr (2006) 0.92
The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana. Malar J (2014) 0.92
Characterisation of norovirus strains in rural Ghanaian children with acute diarrhoea. J Med Virol (2006) 0.92
Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation. Malar J (2014) 0.92
Biochemical and hematologic parameters for children in the middle belt of Ghana. Am J Trop Med Hyg (2014) 0.91
A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs. Malar J (2013) 0.91
Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children. PLoS One (2011) 0.90
Hospital health care cost of diarrheal disease in Northern Ghana. J Infect Dis (2010) 0.89
Inconsistent reporting of female genital cutting status in northern Ghana: explanatory factors and analytical consequences. Stud Fam Plann (2003) 0.88
Association of the GNAS locus with severe malaria. Hum Genet (2008) 0.87
Sulfadoxine-pyrimethamine-based intermittent preventive treatment, bed net use, and antenatal care during pregnancy: demographic trends and impact on the health of newborns in the Kassena Nankana District, northeastern Ghana. Am J Trop Med Hyg (2010) 0.87
Good clinical laboratory practices improved proficiency testing performance at clinical trials centers in Ghana and Burkina Faso. PLoS One (2012) 0.87
Methods for identifying Neisseria meningitidis carriers: a multi-center study in the African meningitis belt. PLoS One (2013) 0.86
Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis. Trop Med Int Health (2011) 0.85